Simple Science

Cutting edge science explained simply

# Biology # Microbiology

The Hidden Threat of Enterobacter in Healthcare

Enterobacter species pose serious infection risks in hospitals due to their drug resistance.

Faith I. Oni, Ayorinde O. Afolayan, Anderson O. Oaikhena, Erkison Ewomazino Odih, Odion O. Ikhimiukor, Veronica O. Ogunleye, Aaron O. Aboderin, Olatunde F. Olabisi, Adewale A. Amupitan, Abayomi Fadeyi, Rasaki A. Raheem, Bashirat A. Olanipekun, Charles J. Elikwu, Oluwadamilola A. Sadare, Phillip O. Oshun, Oyinlola O. Oduyebo, Folashade Ojo, Abolaji T. Adeyemo, Ifeanyi E Mba, Abiodun Egwuenu, Tochi Okwor, Anthony Underwood, Silvia Argimón, Chikwe Ihekweazu, David M. Aanensen, Iruka N. Okeke

― 6 min read


Enterobacter: A Clinical Enterobacter: A Clinical Menace resistance. healthcare with growing drug Enterobacter species challenge
Table of Contents

Enterobacter is a group of bacteria that are mostly found in the intestines of humans and animals. They belong to a larger family of bacteria called Enterobacteriaceae. While these bugs are part of our natural gut population, they can sometimes cause trouble, leading to infections. You might think of them as the uninvited guests at a party – they show up unannounced and can cause quite a mess.

Where Do They Hang Out?

You can find Enterobacter in various places beyond our intestines. They like to chill in water, sewage, soil, and even on plants. Their adaptability makes them widespread, and this is why they can sometimes cause infections in hospitals and other settings.

The Trouble They Cause

Enterobacter species are known to cause various infections, especially in people who are already weakened or ill. These infections can show up in different parts of the body, such as the urinary tract, wounds, lungs, and even the bloodstream. Their ability to resist multiple drugs makes them particularly frustrating for doctors trying to treat infections caused by them. Think of them as the “bad boys” of the bacterial world, cruising through hospitals and causing chaos.

Enterobacter cloacae Complex

Among the different kinds of Enterobacter, there's a particular group known as the Enterobacter cloacae complex, which includes several species. These include Enterobacter cloacae, Enterobacter asburiae, and a few others. Identifying these species can be quite tricky, which adds to the headache for healthcare professionals. It's like trying to find a needle in a haystack, but the needle keeps changing shape!

Why Identification is Hard

Identifying these bacteria accurately is no small feat. Traditional methods, like certain biochemical tests, often fail to pinpoint the specific type of Enterobacter involved. Sometimes, they can be misidentified as something else altogether! Automated systems designed to help with identification can also mix things up. This can lead to incorrect treatments, which is the last thing anyone wants.

The Solution: Whole Genome Sequencing

A modern remedy to this identification challenge is whole genome sequencing (WGS). This technique allows scientists to read the entire genetic makeup of the bacteria. WGS is like having a high-tech magnifying glass that reveals exactly what you are dealing with. By using this method, researchers have been able to spot hidden species that were previously mistaken for other types. It’s opening up a treasure chest of information about these bacteria.

Enterobacter’s Recent History

A study conducted on Enterobacter species isolated from blood infections in Nigerian hospitals between 2014 and 2020 brought some eye-opening findings. The researchers used WGS to identify the bacteria and learn more about them. Out of thousands of samples, a small number were identified as Enterobacter species, highlighting the significance of this group among hospital infections.

Collecting Data

The researchers collected samples from six hospitals, examining blood cultures that had been taken from patients. They gathered metadata, or basic information, about each isolate. Despite a variety of samples, many were mislabeled. This highlights the importance of careful identification in preventing potential outbreaks.

Re-Identifying the Bugs

After isolating the Enterobacter strains, the researchers cleaned them up and re-identified them using modern methods. They also checked how sensitive these strains were to various Antibiotics. Using up-to-date systems helped ensure that the information gathered was accurate. The results were clearer than a sunny day!

The Importance of Accurate Identification

Discovering the true identity of the Enterobacter species involved is crucial because it affects treatment decisions. Knowing the specifics about which bacteria are present helps healthcare professionals pick the right drugs to fight them. Imagine going to a restaurant and ordering the "chefs special," only to find out they don’t have the ingredients – that’s what happens when you misidentify bacteria!

Findings on Antimicrobial Resistance

One of the key concerns for Enterobacter is their resistance to antibiotics. The study identified multiple genes that contribute to this resistance. This can make treating infections much more complicated. The presence of these resistance genes is a sign that Enterobacter can be tricky customers, particularly when it comes to medication.

Diversity of Enterobacter Species

The study uncovered significant diversity among the Enterobacter strains. They found various types and even some new strains not previously documented. Each hospital had its own unique mix of Enterobacter species, which showcases the complexity of these bacteria.

Clusters and Outbreaks

Two potential outbreak clusters were detected in the study. This signals that the bacteria were spreading among patients in the same hospitals, which is alarming. Identifying such clusters is essential for taking action to prevent further infections from spreading.

The Need for Vigilance

The mix-ups that occurred in identifying Enterobacter highlight the need for better practices in laboratories. It's not just about reading a result; it's about understanding what those results mean for patient care. With improved methods, hospitals can better protect their patients and prevent the spread of infections.

Geographic Distribution

The research also examined how Enterobacter species are distributed across Nigeria. It turns out that different areas have different mixes of these bacteria, making some regions more vulnerable to specific infections. Mapping out where these bacteria thrive helps healthcare professionals prepare and respond effectively.

Enterobacter: The New Clinical Challenge

The importance of addressing Enterobacter species in clinical settings cannot be overstated. As more strains become resistant to antibiotics, the fight against these bacteria will require constant vigilance and innovation. We can't let our guard down, or we might find ourselves in a real pickle!

The Future of Enterobacter Research

The findings from this research suggest a need for continued surveillance of Enterobacter species in healthcare. Understanding how these bacteria evolve and spread is essential for developing better treatments and prevention methods. It's a battle that won't be won easily, but with determination and the right tools, we can make progress.

Conclusion

Enterobacter species are sneaky little bacteria that can cause significant issues, especially in healthcare settings. They’re capable of outsmarting traditional diagnostic methods, making accurate identification a real challenge. But with modern techniques like whole genome sequencing, researchers are starting to shine a light on these tricky characters. The road ahead requires ongoing attention and adaptability to combat the ever-present threat posed by these bacteria. Just remember, keeping an eye on the Enterobacter gang is crucial for a safer healthcare environment!

Original Source

Title: Whole genome Sequencing Reveals Enterobacter hormaechei as a key Bloodstream Pathogen in six tertiary care hospitals in southwestern Nigeria.

Abstract: Enterobacter spp. are an important cause of healthcare-associated bloodstream infections uncommonly reported in Africa. This study used whole genome sequencing (WGS) to characterise Enterobacter spp. from hospitals in Nigerias antimicrobial resistance (AMR) surveillance system. Blood-culture isolates of Enterobacter from six such tertiary-care hospitals recovered between 2014 and 2020 were re-identified and antimicrobial susceptibility-tested using VITEK2. Illumina technology provided whole genome sequences for genome nomenclature, antimicrobial resistance gene prediction, Single Nucleotide Polymorphism (SNP) phylogeny, and multi-locus sequence typing via publicly available bioinformatics pipelines. Initial biochemical delineation often misclassified Enterobacter, necessitating whole-genome sequencing for accurate classification. Among 98 Enterobacter received, Enterobacter hormaechei subspecies xiangfangensis predominated (43), followed by other E. hormachei subspecies (18), E. cloacae (26), E. roggenkampii (4), E. bugandensis (3), E. kobei (2), E. asburiae (1) and E. cancerogenous (1). Cephalosporins, aminoglycoside, chloramphenicol, macrolide, and carbapenem resistance in E. hormaechei was attributed to known resistance genes. They belonged to clusters III, IV, and VIII based on hsp60 typing and clades A, B, C, and D according to Sutton and Cos nomenclature. These isolates and other Enterobacter species recently reported from Nigeria reveal extensive E. hormaechei diversity, as well as clusters representing potential outbreaks. Enterobacter hormaechei, often misidentified and rarely reported from Nigeria, is this studys most common blood culture isolated Enterobacter spp. Uncovering underappreciated species as important bloodstream pathogens and retrospective detection of likely outbreaks emphasise the value of genomic surveillance in resource-limited settings. DATA SUMMARYAll sequence reads were submitted to the European Nucleotide Archive (ENA) under the project ID PRJEB29739 (https://www.ebi.ac.uk/ena/browser/view/PRJEB29739). Accessions can be found in Table S1. IMPACT STATEMENTAccurate identification of Enterobacter is essential in healthcare settings as misidentification can lead to selecting antimicrobials to the genus is intrinsically resistant resistant before susceptibility testing results are available. Also, misidentification can compromise microbiology support for infection prevention and control. We show that E. hormaechei, which is never reported from clinical laboratories in Nigeria, is frequently misidentified using conventional methods like tube- or strip biochemical testing and VITEK systems. Whole genome sequence data demonstrates that E. hormaechei and E. cloacae are the most common Enterobacter isolated from bloodstream infections in Nigeria. Enhanced identification methods for surveillance play pivotal roles in improving patient care, optimising antibiotic stewardship, and combating the evolving challenges posed by this pathogen. Overall, this study reveals the effectiveness of WGS in correctly identifying this important pathogen.

Authors: Faith I. Oni, Ayorinde O. Afolayan, Anderson O. Oaikhena, Erkison Ewomazino Odih, Odion O. Ikhimiukor, Veronica O. Ogunleye, Aaron O. Aboderin, Olatunde F. Olabisi, Adewale A. Amupitan, Abayomi Fadeyi, Rasaki A. Raheem, Bashirat A. Olanipekun, Charles J. Elikwu, Oluwadamilola A. Sadare, Phillip O. Oshun, Oyinlola O. Oduyebo, Folashade Ojo, Abolaji T. Adeyemo, Ifeanyi E Mba, Abiodun Egwuenu, Tochi Okwor, Anthony Underwood, Silvia Argimón, Chikwe Ihekweazu, David M. Aanensen, Iruka N. Okeke

Last Update: 2024-12-02 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.12.02.626058

Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.02.626058.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

More from authors

Similar Articles